Scinovex
article Open AccessTop 1% cited

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Proceedings of the National Academy of Sciences · 1985 · Vol. 82(12) · pp. 4245–4249

Abstract

We have purified and characterized the cerebral amyloid protein that forms the plaque core in Alzheimer disease and in aged individuals with Down syndrome. The protein consists of multimeric aggregates of a polypeptide of about 40 residues (4 kDa). The amino acid composition, molecular mass, and NH2-terminal sequence of this amyloid protein are almost identical to those described for the amyloid deposited in the congophilic angiopathy of Alzheimer disease and Down syndrome, but the plaque core proteins have ragged NH2 termini. The shared 4-kDa subunit indicates a common origin for the amyloids of the plaque core and of the congophilic angiopathy. There are superficial resemblances between the solubility characteristics of the plaque core and some of the properties of scrapie infectivity, but there are no similarities in amino acid sequences between the plaque core and scrapie polypeptides.

Alzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingNeurological diseases and metabolismAmyloid (mycology)Protein subunitScrapieCerebral amyloid angiopathySenile plaquesAlzheimer's diseaseAngiopathyPeptide sequenceChemistryBiology

MeSH terms

Alzheimer DiseaseAmino Acid SequenceAmino AcidsAmyloidBrainDown SyndromeHumansMolecular WeightSolubility
Citations
4,412
FWCI
58.81
field-weighted impact
References
7
Percentile
100%
vs. same field & year
Citations per year
References
Abnormal fibrils from scrapie-infected brain
Acta Neuropathologica · 1981 · 467 citations
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Biochemical and Biophysical Research Communications · 1984 · 1,668 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.